Immunosuppressive effect of cholera toxin B on allergic conjunctivitis model in guinea pig.
OBJECTIVE
To investigate the new method of immunotherapy using cholera toxin B (CTB) in experimental allergic conjunctivitis.


METHODS
We used 21 white Hartley guinea pigs. The animals were sensitized by intraperitoneal injection of ovalbumin (100 microg/mL) and albumin hydroxide (5 mg/mL) repeated after an interval of 2 weeks. One week after the second injection, conjunctivitis was induced by topical instillation of ovalbumin (5 mg/mL). The animals were divided into two groups, CTB group and control group. The CTB group underwent pretreatment of topical instillation of CTB (4 microg/30 mL) and ovalbumin (10 microg/30 mL), three times a day for 3 days, 1 week before the intraperitoneal injection. The control group did not undergo the pretreatment. Clinical examination was performed at 0.5, 6, and 24 hours after the development of conjunctivitis. Histological examination was performed at 6 and 24 hours.


RESULTS
Both groups developed palpebral and bulbar edema with hyperemia 30 minutes after instillation of ovalbumin. The allergic reaction score was significantly less in the CTB group than in the control group (Mann-Whitney U-test: P <.01). The clinical reactions subsided after 6 hours. The CTB group showed less eosinophilic infiltration in the conjunctiva and the limbus, particularly in the conjunctival epithelium, than the control group at 6 and 24 hours.


CONCLUSIONS
Pretreatment with topical CTB and antigen suppresses clinical and histological findings in experimentally induced allergic conjunctivitis.
Saito
K
K
Department of Ophthalmology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Shoji
J
J
Inada
N
N
Iwasaki
Y
Y
Sawa
M
M
D000818:Animals; D002772:Cholera Toxin / Q000627:therapeutic use*; D003233:Conjunctivitis, Allergic / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D004195:Disease Models, Animal; D005260:Female; D006168:Guinea Pigs; D018928:Immunity, Mucosal; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods; D010047:Ovalbumin
D007166:Immunosuppressive Agents; D010047:Ovalbumin; D002772:Cholera Toxin